nodes	percent_of_prediction	percent_of_DWPC	metapath
Albendazole—CYP1A1—Cholecalciferol—osteoporosis	0.0939	0.141	CbGbCtD
Albendazole—CYP1A2—Estropipate—osteoporosis	0.0815	0.122	CbGbCtD
Albendazole—CYP1A1—Estradiol—osteoporosis	0.0757	0.113	CbGbCtD
Albendazole—ABCB1—Ethinyl Estradiol—osteoporosis	0.0459	0.0687	CbGbCtD
Albendazole—CYP3A4—Estropipate—osteoporosis	0.0427	0.0639	CbGbCtD
Albendazole—CYP3A4—Calcitriol—osteoporosis	0.0427	0.0639	CbGbCtD
Albendazole—CYP1A2—Conjugated Estrogens—osteoporosis	0.0385	0.0577	CbGbCtD
Albendazole—CYP3A4—Ergocalciferol—osteoporosis	0.0341	0.0511	CbGbCtD
Albendazole—CYP1A2—Estradiol—osteoporosis	0.0338	0.0506	CbGbCtD
Albendazole—ABCB1—Conjugated Estrogens—osteoporosis	0.0337	0.0504	CbGbCtD
Albendazole—ABCB1—Estradiol—osteoporosis	0.0296	0.0443	CbGbCtD
Albendazole—CYP3A4—Raloxifene—osteoporosis	0.0285	0.0426	CbGbCtD
Albendazole—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0275	0.0412	CbGbCtD
Albendazole—CYP3A4—Cholecalciferol—osteoporosis	0.022	0.0329	CbGbCtD
Albendazole—CYP3A4—Conjugated Estrogens—osteoporosis	0.0202	0.0302	CbGbCtD
Albendazole—CYP3A4—Estradiol—osteoporosis	0.0177	0.0265	CbGbCtD
Albendazole—TUBB4B—Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding—CCT2—osteoporosis	0.00471	0.0293	CbGpPWpGaD
Albendazole—TUBA1A—Protein folding—CCT2—osteoporosis	0.00455	0.0282	CbGpPWpGaD
Albendazole—TUBA1A—Chaperonin-mediated protein folding—TUBA1B—osteoporosis	0.00424	0.0263	CbGpPWpGaD
Albendazole—TUBB4B—Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding—TUBA1B—osteoporosis	0.00401	0.0249	CbGpPWpGaD
Albendazole—TUBA1A—Protein folding—TUBA1B—osteoporosis	0.00387	0.024	CbGpPWpGaD
Albendazole—TUBA1A—Pathogenic Escherichia coli infection—TUBA1B—osteoporosis	0.00387	0.024	CbGpPWpGaD
Albendazole—ABCB1—Drug Induction of Bile Acid Pathway—SLC51A—osteoporosis	0.00372	0.0231	CbGpPWpGaD
Albendazole—TUBA1A—Parkin-Ubiquitin Proteasomal System pathway—TUBA1B—osteoporosis	0.00319	0.0198	CbGpPWpGaD
Albendazole—TUBB4B—Chaperonin-mediated protein folding—CCT2—osteoporosis	0.00301	0.0187	CbGpPWpGaD
Albendazole—TUBB4B—Protein folding—CCT2—osteoporosis	0.00275	0.0171	CbGpPWpGaD
Albendazole—TUBA1A—Pathogenic Escherichia coli infection—ACTG1—osteoporosis	0.00268	0.0166	CbGpPWpGaD
Albendazole—TUBB4B—Chaperonin-mediated protein folding—TUBA1B—osteoporosis	0.00256	0.0159	CbGpPWpGaD
Albendazole—TUBB4B—Pathogenic Escherichia coli infection—TUBA1B—osteoporosis	0.00234	0.0145	CbGpPWpGaD
Albendazole—TUBB4B—Protein folding—TUBA1B—osteoporosis	0.00234	0.0145	CbGpPWpGaD
Albendazole—CYP3A4—Drug Induction of Bile Acid Pathway—SLC51A—osteoporosis	0.00229	0.0142	CbGpPWpGaD
Albendazole—Renal failure acute—Ibandronate—osteoporosis	0.00205	0.012	CcSEcCtD
Albendazole—TUBB4B—Parkin-Ubiquitin Proteasomal System pathway—TUBA1B—osteoporosis	0.00193	0.012	CbGpPWpGaD
Albendazole—Pancytopenia—Etidronic acid—osteoporosis	0.00187	0.0109	CcSEcCtD
Albendazole—Stevens-Johnson syndrome—Etidronic acid—osteoporosis	0.00174	0.0102	CcSEcCtD
Albendazole—Agranulocytosis—Etidronic acid—osteoporosis	0.00164	0.00958	CcSEcCtD
Albendazole—TUBB4B—Pathogenic Escherichia coli infection—ACTG1—osteoporosis	0.00162	0.0101	CbGpPWpGaD
Albendazole—Renal failure acute—Pamidronate—osteoporosis	0.0016	0.00938	CcSEcCtD
Albendazole—Erythema multiforme—Etidronic acid—osteoporosis	0.00149	0.00871	CcSEcCtD
Albendazole—Stevens-Johnson syndrome—Alendronate—osteoporosis	0.00148	0.00867	CcSEcCtD
Albendazole—Renal failure acute—Zoledronate—osteoporosis	0.00147	0.00857	CcSEcCtD
Albendazole—Liver function test abnormal—Risedronate—osteoporosis	0.00144	0.00841	CcSEcCtD
Albendazole—Hepatobiliary disease—Estropipate—osteoporosis	0.00144	0.0084	CcSEcCtD
Albendazole—Renal failure acute—Conjugated Estrogens—osteoporosis	0.00141	0.00825	CcSEcCtD
Albendazole—Alopecia—Etidronic acid—osteoporosis	0.00139	0.00814	CcSEcCtD
Albendazole—Hepatobiliary disease—Ibandronate—osteoporosis	0.00138	0.00806	CcSEcCtD
Albendazole—Liver function test abnormal—Pamidronate—osteoporosis	0.00137	0.00799	CcSEcCtD
Albendazole—Urinary tract disorder—Raloxifene—osteoporosis	0.0013	0.00763	CcSEcCtD
Albendazole—Urethral disorder—Raloxifene—osteoporosis	0.00129	0.00757	CcSEcCtD
Albendazole—Urinary tract disorder—Ibandronate—osteoporosis	0.00129	0.00755	CcSEcCtD
Albendazole—Erythema multiforme—Estropipate—osteoporosis	0.00129	0.00754	CcSEcCtD
Albendazole—Urethral disorder—Ibandronate—osteoporosis	0.00128	0.00749	CcSEcCtD
Albendazole—Erythema multiforme—Alendronate—osteoporosis	0.00127	0.00743	CcSEcCtD
Albendazole—Hypersensitivity—Calcium Acetate—osteoporosis	0.00126	0.00735	CcSEcCtD
Albendazole—Immune system disorder—Estropipate—osteoporosis	0.00123	0.0072	CcSEcCtD
Albendazole—Leukopenia—Etidronic acid—osteoporosis	0.00123	0.00718	CcSEcCtD
Albendazole—Erythema multiforme—Calcitriol—osteoporosis	0.00121	0.00708	CcSEcCtD
Albendazole—Alopecia—Estropipate—osteoporosis	0.0012	0.00705	CcSEcCtD
Albendazole—Neutropenia—Pamidronate—osteoporosis	0.0012	0.007	CcSEcCtD
Albendazole—Alopecia—Alendronate—osteoporosis	0.00119	0.00694	CcSEcCtD
Albendazole—Immune system disorder—Ibandronate—osteoporosis	0.00118	0.00691	CcSEcCtD
Albendazole—Alopecia—Ibandronate—osteoporosis	0.00116	0.00676	CcSEcCtD
Albendazole—TUBB4B—Orphan transporters—ANXA2—osteoporosis	0.00114	0.0071	CbGpPWpGaD
Albendazole—Hepatobiliary disease—Risedronate—osteoporosis	0.00114	0.00664	CcSEcCtD
Albendazole—Dizziness—Calcium Acetate—osteoporosis	0.00113	0.0066	CcSEcCtD
Albendazole—Pancytopenia—Zoledronate—osteoporosis	0.00111	0.00649	CcSEcCtD
Albendazole—Neutropenia—Zoledronate—osteoporosis	0.00109	0.00639	CcSEcCtD
Albendazole—Urinary tract disorder—Ethinyl Estradiol—osteoporosis	0.00109	0.00638	CcSEcCtD
Albendazole—Vomiting—Calcium Acetate—osteoporosis	0.00108	0.00634	CcSEcCtD
Albendazole—Urethral disorder—Ethinyl Estradiol—osteoporosis	0.00108	0.00634	CcSEcCtD
Albendazole—Vertigo—Estropipate—osteoporosis	0.00107	0.00624	CcSEcCtD
Albendazole—Agranulocytosis—Pamidronate—osteoporosis	0.00106	0.00623	CcSEcCtD
Albendazole—Urinary tract disorder—Risedronate—osteoporosis	0.00106	0.00622	CcSEcCtD
Albendazole—Urethral disorder—Risedronate—osteoporosis	0.00106	0.00618	CcSEcCtD
Albendazole—Vertigo—Alendronate—osteoporosis	0.00105	0.00614	CcSEcCtD
Albendazole—Erythema multiforme—Ethinyl Estradiol—osteoporosis	0.00105	0.00611	CcSEcCtD
Albendazole—Vertigo—Raloxifene—osteoporosis	0.00103	0.00604	CcSEcCtD
Albendazole—Vertigo—Ibandronate—osteoporosis	0.00102	0.00598	CcSEcCtD
Albendazole—Nausea—Calcium Acetate—osteoporosis	0.00101	0.00592	CcSEcCtD
Albendazole—Urinary tract disorder—Pamidronate—osteoporosis	0.00101	0.00592	CcSEcCtD
Albendazole—Urethral disorder—Pamidronate—osteoporosis	0.001	0.00587	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Estropipate—osteoporosis	0.001	0.00587	CcSEcCtD
Albendazole—Immune system disorder—Ethinyl Estradiol—osteoporosis	0.000998	0.00584	CcSEcCtD
Albendazole—Alopecia—Ethinyl Estradiol—osteoporosis	0.000977	0.00571	CcSEcCtD
Albendazole—Immune system disorder—Risedronate—osteoporosis	0.000973	0.00569	CcSEcCtD
Albendazole—Agranulocytosis—Zoledronate—osteoporosis	0.000973	0.00569	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Raloxifene—osteoporosis	0.000972	0.00568	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Ibandronate—osteoporosis	0.000962	0.00563	CcSEcCtD
Albendazole—Liver function test abnormal—Estradiol—osteoporosis	0.000962	0.00563	CcSEcCtD
Albendazole—Hepatobiliary disease—Conjugated Estrogens—osteoporosis	0.000949	0.00555	CcSEcCtD
Albendazole—Skin disorder—Estropipate—osteoporosis	0.000941	0.0055	CcSEcCtD
Albendazole—Immune system disorder—Pamidronate—osteoporosis	0.000925	0.00541	CcSEcCtD
Albendazole—Urinary tract disorder—Zoledronate—osteoporosis	0.000924	0.0054	CcSEcCtD
Albendazole—Thrombocytopenia—Raloxifene—osteoporosis	0.000919	0.00537	CcSEcCtD
Albendazole—Urethral disorder—Zoledronate—osteoporosis	0.000917	0.00536	CcSEcCtD
Albendazole—Gastrointestinal pain—Etidronic acid—osteoporosis	0.000916	0.00535	CcSEcCtD
Albendazole—Skin disorder—Raloxifene—osteoporosis	0.000911	0.00533	CcSEcCtD
Albendazole—Alopecia—Pamidronate—osteoporosis	0.000905	0.00529	CcSEcCtD
Albendazole—Skin disorder—Ibandronate—osteoporosis	0.000902	0.00528	CcSEcCtD
Albendazole—Nausea—Ergocalciferol—osteoporosis	0.000895	0.00523	CcSEcCtD
Albendazole—Urticaria—Etidronic acid—osteoporosis	0.00089	0.0052	CcSEcCtD
Albendazole—Abdominal pain—Etidronic acid—osteoporosis	0.000885	0.00518	CcSEcCtD
Albendazole—Skin disorder—Calcitriol—osteoporosis	0.000883	0.00517	CcSEcCtD
Albendazole—Erythema multiforme—Conjugated Estrogens—osteoporosis	0.000852	0.00498	CcSEcCtD
Albendazole—Immune system disorder—Zoledronate—osteoporosis	0.000845	0.00494	CcSEcCtD
Albendazole—Vertigo—Risedronate—osteoporosis	0.000843	0.00493	CcSEcCtD
Albendazole—Alopecia—Zoledronate—osteoporosis	0.000827	0.00483	CcSEcCtD
Albendazole—Hypersensitivity—Etidronic acid—osteoporosis	0.000825	0.00482	CcSEcCtD
Albendazole—Immune system disorder—Conjugated Estrogens—osteoporosis	0.000814	0.00476	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Ethinyl Estradiol—osteoporosis	0.000813	0.00476	CcSEcCtD
Albendazole—Leukopenia—Pamidronate—osteoporosis	0.000798	0.00467	CcSEcCtD
Albendazole—Alopecia—Conjugated Estrogens—osteoporosis	0.000796	0.00466	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Risedronate—osteoporosis	0.000793	0.00464	CcSEcCtD
Albendazole—Gastrointestinal pain—Estropipate—osteoporosis	0.000792	0.00463	CcSEcCtD
Albendazole—Gastrointestinal pain—Alendronate—osteoporosis	0.00078	0.00456	CcSEcCtD
Albendazole—Urticaria—Estropipate—osteoporosis	0.00077	0.0045	CcSEcCtD
Albendazole—Gastrointestinal pain—Raloxifene—osteoporosis	0.000767	0.00449	CcSEcCtD
Albendazole—Abdominal pain—Estropipate—osteoporosis	0.000766	0.00448	CcSEcCtD
Albendazole—Body temperature increased—Estropipate—osteoporosis	0.000766	0.00448	CcSEcCtD
Albendazole—Skin disorder—Ethinyl Estradiol—osteoporosis	0.000763	0.00446	CcSEcCtD
Albendazole—ABCB1—HIF-1-alpha transcription factor network—PKM—osteoporosis	0.000761	0.00473	CbGpPWpGaD
Albendazole—Hepatobiliary disease—Estradiol—osteoporosis	0.00076	0.00444	CcSEcCtD
Albendazole—Gastrointestinal pain—Ibandronate—osteoporosis	0.00076	0.00444	CcSEcCtD
Albendazole—Urticaria—Alendronate—osteoporosis	0.000758	0.00443	CcSEcCtD
Albendazole—Abdominal pain—Alendronate—osteoporosis	0.000754	0.00441	CcSEcCtD
Albendazole—Body temperature increased—Alendronate—osteoporosis	0.000754	0.00441	CcSEcCtD
Albendazole—Skin disorder—Risedronate—osteoporosis	0.000744	0.00435	CcSEcCtD
Albendazole—Gastrointestinal pain—Calcitriol—osteoporosis	0.000744	0.00435	CcSEcCtD
Albendazole—Abdominal pain—Raloxifene—osteoporosis	0.000742	0.00434	CcSEcCtD
Albendazole—Body temperature increased—Raloxifene—osteoporosis	0.000742	0.00434	CcSEcCtD
Albendazole—Urticaria—Ibandronate—osteoporosis	0.000738	0.00432	CcSEcCtD
Albendazole—Abdominal pain—Ibandronate—osteoporosis	0.000734	0.00429	CcSEcCtD
Albendazole—Body temperature increased—Ibandronate—osteoporosis	0.000734	0.00429	CcSEcCtD
Albendazole—Vertigo—Zoledronate—osteoporosis	0.000732	0.00428	CcSEcCtD
Albendazole—Leukopenia—Zoledronate—osteoporosis	0.000729	0.00426	CcSEcCtD
Albendazole—Urticaria—Calcitriol—osteoporosis	0.000722	0.00422	CcSEcCtD
Albendazole—Hepatitis—Estradiol—osteoporosis	0.000721	0.00422	CcSEcCtD
Albendazole—Abdominal pain—Calcitriol—osteoporosis	0.000719	0.0042	CcSEcCtD
Albendazole—Body temperature increased—Calcitriol—osteoporosis	0.000719	0.0042	CcSEcCtD
Albendazole—Hypersensitivity—Estropipate—osteoporosis	0.000714	0.00417	CcSEcCtD
Albendazole—Thrombocytopenia—Pamidronate—osteoporosis	0.000713	0.00417	CcSEcCtD
Albendazole—Urinary tract disorder—Estradiol—osteoporosis	0.000712	0.00416	CcSEcCtD
Albendazole—Vomiting—Etidronic acid—osteoporosis	0.000712	0.00416	CcSEcCtD
Albendazole—Urethral disorder—Estradiol—osteoporosis	0.000707	0.00413	CcSEcCtD
Albendazole—Rash—Etidronic acid—osteoporosis	0.000706	0.00413	CcSEcCtD
Albendazole—Dermatitis—Etidronic acid—osteoporosis	0.000705	0.00412	CcSEcCtD
Albendazole—Vertigo—Conjugated Estrogens—osteoporosis	0.000705	0.00412	CcSEcCtD
Albendazole—CYP1A1—Estrogen Receptor Pathway—ESR1—osteoporosis	0.000704	0.00437	CbGpPWpGaD
Albendazole—Hypersensitivity—Alendronate—osteoporosis	0.000703	0.00411	CcSEcCtD
Albendazole—Headache—Etidronic acid—osteoporosis	0.000701	0.0041	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000689	0.00403	CcSEcCtD
Albendazole—Hypersensitivity—Ibandronate—osteoporosis	0.000684	0.004	CcSEcCtD
Albendazole—Erythema multiforme—Estradiol—osteoporosis	0.000682	0.00399	CcSEcCtD
Albendazole—Hypersensitivity—Calcitriol—osteoporosis	0.00067	0.00392	CcSEcCtD
Albendazole—Nausea—Etidronic acid—osteoporosis	0.000665	0.00389	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000663	0.00388	CcSEcCtD
Albendazole—Immune system disorder—Estradiol—osteoporosis	0.000651	0.00381	CcSEcCtD
Albendazole—Thrombocytopenia—Zoledronate—osteoporosis	0.000651	0.00381	CcSEcCtD
Albendazole—Skin disorder—Zoledronate—osteoporosis	0.000646	0.00378	CcSEcCtD
Albendazole—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000642	0.00375	CcSEcCtD
Albendazole—Dizziness—Estropipate—osteoporosis	0.000641	0.00375	CcSEcCtD
Albendazole—Alopecia—Estradiol—osteoporosis	0.000637	0.00373	CcSEcCtD
Albendazole—Dizziness—Alendronate—osteoporosis	0.000631	0.00369	CcSEcCtD
Albendazole—Gastrointestinal pain—Risedronate—osteoporosis	0.000626	0.00366	CcSEcCtD
Albendazole—Urticaria—Ethinyl Estradiol—osteoporosis	0.000624	0.00365	CcSEcCtD
Albendazole—Skin disorder—Conjugated Estrogens—osteoporosis	0.000622	0.00364	CcSEcCtD
Albendazole—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000621	0.00363	CcSEcCtD
Albendazole—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000621	0.00363	CcSEcCtD
Albendazole—Dizziness—Raloxifene—osteoporosis	0.000621	0.00363	CcSEcCtD
Albendazole—Vomiting—Estropipate—osteoporosis	0.000616	0.0036	CcSEcCtD
Albendazole—Dizziness—Ibandronate—osteoporosis	0.000614	0.00359	CcSEcCtD
Albendazole—Rash—Estropipate—osteoporosis	0.000611	0.00357	CcSEcCtD
Albendazole—Dermatitis—Estropipate—osteoporosis	0.00061	0.00357	CcSEcCtD
Albendazole—Urticaria—Risedronate—osteoporosis	0.000608	0.00356	CcSEcCtD
Albendazole—Headache—Estropipate—osteoporosis	0.000607	0.00355	CcSEcCtD
Albendazole—Vomiting—Alendronate—osteoporosis	0.000607	0.00355	CcSEcCtD
Albendazole—TUBA1A—Metabolism of proteins—CCT2—osteoporosis	0.000606	0.00376	CbGpPWpGaD
Albendazole—Abdominal pain—Risedronate—osteoporosis	0.000605	0.00354	CcSEcCtD
Albendazole—Body temperature increased—Risedronate—osteoporosis	0.000605	0.00354	CcSEcCtD
Albendazole—Rash—Alendronate—osteoporosis	0.000602	0.00352	CcSEcCtD
Albendazole—Dermatitis—Alendronate—osteoporosis	0.000601	0.00351	CcSEcCtD
Albendazole—Headache—Alendronate—osteoporosis	0.000598	0.0035	CcSEcCtD
Albendazole—Vomiting—Raloxifene—osteoporosis	0.000597	0.00349	CcSEcCtD
Albendazole—Gastrointestinal pain—Pamidronate—osteoporosis	0.000595	0.00348	CcSEcCtD
Albendazole—ABCB1—Drug Induction of Bile Acid Pathway—VDR—osteoporosis	0.000594	0.00369	CbGpPWpGaD
Albendazole—Rash—Raloxifene—osteoporosis	0.000592	0.00346	CcSEcCtD
Albendazole—Dermatitis—Raloxifene—osteoporosis	0.000591	0.00346	CcSEcCtD
Albendazole—Vomiting—Ibandronate—osteoporosis	0.000591	0.00345	CcSEcCtD
Albendazole—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.000591	0.00367	CbGpPWpGaD
Albendazole—Headache—Raloxifene—osteoporosis	0.000588	0.00344	CcSEcCtD
Albendazole—Rash—Ibandronate—osteoporosis	0.000586	0.00342	CcSEcCtD
Albendazole—Dermatitis—Ibandronate—osteoporosis	0.000585	0.00342	CcSEcCtD
Albendazole—CYP1A1—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.000583	0.00362	CbGpPWpGaD
Albendazole—Headache—Ibandronate—osteoporosis	0.000582	0.0034	CcSEcCtD
Albendazole—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000579	0.00338	CcSEcCtD
Albendazole—Vomiting—Calcitriol—osteoporosis	0.000578	0.00338	CcSEcCtD
Albendazole—Nausea—Estropipate—osteoporosis	0.000575	0.00336	CcSEcCtD
Albendazole—Abdominal pain—Pamidronate—osteoporosis	0.000575	0.00336	CcSEcCtD
Albendazole—Body temperature increased—Pamidronate—osteoporosis	0.000575	0.00336	CcSEcCtD
Albendazole—Rash—Calcitriol—osteoporosis	0.000573	0.00335	CcSEcCtD
Albendazole—Dermatitis—Calcitriol—osteoporosis	0.000573	0.00335	CcSEcCtD
Albendazole—Headache—Calcitriol—osteoporosis	0.00057	0.00333	CcSEcCtD
Albendazole—Nausea—Alendronate—osteoporosis	0.000567	0.00331	CcSEcCtD
Albendazole—Hypersensitivity—Risedronate—osteoporosis	0.000564	0.0033	CcSEcCtD
Albendazole—Vertigo—Estradiol—osteoporosis	0.000564	0.0033	CcSEcCtD
Albendazole—Nausea—Raloxifene—osteoporosis	0.000557	0.00326	CcSEcCtD
Albendazole—Nausea—Ibandronate—osteoporosis	0.000552	0.00323	CcSEcCtD
Albendazole—Gastrointestinal pain—Zoledronate—osteoporosis	0.000544	0.00318	CcSEcCtD
Albendazole—Nausea—Calcitriol—osteoporosis	0.00054	0.00316	CcSEcCtD
Albendazole—Hypersensitivity—Pamidronate—osteoporosis	0.000536	0.00314	CcSEcCtD
Albendazole—ABCB1—Allograft Rejection—TUBA1B—osteoporosis	0.000531	0.0033	CbGpPWpGaD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000531	0.0031	CcSEcCtD
Albendazole—Urticaria—Zoledronate—osteoporosis	0.000528	0.00309	CcSEcCtD
Albendazole—Body temperature increased—Zoledronate—osteoporosis	0.000526	0.00307	CcSEcCtD
Albendazole—Abdominal pain—Zoledronate—osteoporosis	0.000526	0.00307	CcSEcCtD
Albendazole—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000523	0.00306	CcSEcCtD
Albendazole—Dizziness—Ethinyl Estradiol—osteoporosis	0.000519	0.00304	CcSEcCtD
Albendazole—TUBA1A—Metabolism of proteins—TUBA1B—osteoporosis	0.000516	0.0032	CbGpPWpGaD
Albendazole—Urticaria—Conjugated Estrogens—osteoporosis	0.000509	0.00297	CcSEcCtD
Albendazole—Dizziness—Risedronate—osteoporosis	0.000506	0.00296	CcSEcCtD
Albendazole—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000506	0.00296	CcSEcCtD
Albendazole—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000506	0.00296	CcSEcCtD
Albendazole—Vomiting—Ethinyl Estradiol—osteoporosis	0.000499	0.00292	CcSEcCtD
Albendazole—Skin disorder—Estradiol—osteoporosis	0.000498	0.00291	CcSEcCtD
Albendazole—Rash—Ethinyl Estradiol—osteoporosis	0.000495	0.0029	CcSEcCtD
Albendazole—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000495	0.00289	CcSEcCtD
Albendazole—Headache—Ethinyl Estradiol—osteoporosis	0.000492	0.00288	CcSEcCtD
Albendazole—Hypersensitivity—Zoledronate—osteoporosis	0.00049	0.00286	CcSEcCtD
Albendazole—Vomiting—Risedronate—osteoporosis	0.000487	0.00285	CcSEcCtD
Albendazole—Rash—Risedronate—osteoporosis	0.000483	0.00282	CcSEcCtD
Albendazole—Dermatitis—Risedronate—osteoporosis	0.000482	0.00282	CcSEcCtD
Albendazole—Dizziness—Pamidronate—osteoporosis	0.000481	0.00281	CcSEcCtD
Albendazole—Headache—Risedronate—osteoporosis	0.00048	0.0028	CcSEcCtD
Albendazole—CYP1A1—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.000479	0.00297	CbGpPWpGaD
Albendazole—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000472	0.00276	CcSEcCtD
Albendazole—Nausea—Ethinyl Estradiol—osteoporosis	0.000466	0.00273	CcSEcCtD
Albendazole—Vomiting—Pamidronate—osteoporosis	0.000463	0.00271	CcSEcCtD
Albendazole—CYP1A1—Oxidative Stress—SOD2—osteoporosis	0.000461	0.00286	CbGpPWpGaD
Albendazole—Rash—Pamidronate—osteoporosis	0.000459	0.00268	CcSEcCtD
Albendazole—Dermatitis—Pamidronate—osteoporosis	0.000458	0.00268	CcSEcCtD
Albendazole—Headache—Pamidronate—osteoporosis	0.000456	0.00267	CcSEcCtD
Albendazole—Nausea—Risedronate—osteoporosis	0.000455	0.00266	CcSEcCtD
Albendazole—CYP1A2—Estrogen Receptor Pathway—ESR1—osteoporosis	0.000449	0.00279	CbGpPWpGaD
Albendazole—CYP1A1—Oxidative Stress—GPX1—osteoporosis	0.00044	0.00273	CbGpPWpGaD
Albendazole—Dizziness—Zoledronate—osteoporosis	0.00044	0.00257	CcSEcCtD
Albendazole—Nausea—Pamidronate—osteoporosis	0.000432	0.00253	CcSEcCtD
Albendazole—Dizziness—Conjugated Estrogens—osteoporosis	0.000423	0.00248	CcSEcCtD
Albendazole—Vomiting—Zoledronate—osteoporosis	0.000423	0.00247	CcSEcCtD
Albendazole—Rash—Zoledronate—osteoporosis	0.000419	0.00245	CcSEcCtD
Albendazole—Gastrointestinal pain—Estradiol—osteoporosis	0.000419	0.00245	CcSEcCtD
Albendazole—Dermatitis—Zoledronate—osteoporosis	0.000419	0.00245	CcSEcCtD
Albendazole—Headache—Zoledronate—osteoporosis	0.000416	0.00244	CcSEcCtD
Albendazole—TUBA1A—Metabolism of proteins—RPL24—osteoporosis	0.000412	0.00256	CbGpPWpGaD
Albendazole—Vomiting—Conjugated Estrogens—osteoporosis	0.000407	0.00238	CcSEcCtD
Albendazole—Urticaria—Estradiol—osteoporosis	0.000407	0.00238	CcSEcCtD
Albendazole—Abdominal pain—Estradiol—osteoporosis	0.000405	0.00237	CcSEcCtD
Albendazole—Body temperature increased—Estradiol—osteoporosis	0.000405	0.00237	CcSEcCtD
Albendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—GPD2—osteoporosis	0.000405	0.00251	CbGpPWpGaD
Albendazole—Rash—Conjugated Estrogens—osteoporosis	0.000404	0.00236	CcSEcCtD
Albendazole—Dermatitis—Conjugated Estrogens—osteoporosis	0.000403	0.00236	CcSEcCtD
Albendazole—Headache—Conjugated Estrogens—osteoporosis	0.000401	0.00234	CcSEcCtD
Albendazole—Nausea—Zoledronate—osteoporosis	0.000395	0.00231	CcSEcCtD
Albendazole—CYP1A1—Tryptophan metabolism—CYP19A1—osteoporosis	0.000384	0.00238	CbGpPWpGaD
Albendazole—Nausea—Conjugated Estrogens—osteoporosis	0.00038	0.00222	CcSEcCtD
Albendazole—Hypersensitivity—Estradiol—osteoporosis	0.000377	0.00221	CcSEcCtD
Albendazole—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.000377	0.00234	CbGpPWpGaD
Albendazole—TUBA1A—p73 transcription factor network—MYC—osteoporosis	0.000376	0.00234	CbGpPWpGaD
Albendazole—CYP1A2—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.000372	0.00231	CbGpPWpGaD
Albendazole—TUBB4B—Metabolism of proteins—CCT2—osteoporosis	0.000366	0.00227	CbGpPWpGaD
Albendazole—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—osteoporosis	0.000366	0.00227	CbGpPWpGaD
Albendazole—TUBA1A—Metabolism of proteins—TLN1—osteoporosis	0.000362	0.00225	CbGpPWpGaD
Albendazole—TUBA1A—Metabolism of proteins—REN—osteoporosis	0.000348	0.00216	CbGpPWpGaD
Albendazole—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	0.000341	0.00212	CbGpPWpGaD
Albendazole—Dizziness—Estradiol—osteoporosis	0.000339	0.00198	CcSEcCtD
Albendazole—Vomiting—Estradiol—osteoporosis	0.000326	0.0019	CcSEcCtD
Albendazole—Rash—Estradiol—osteoporosis	0.000323	0.00189	CcSEcCtD
Albendazole—Dermatitis—Estradiol—osteoporosis	0.000323	0.00189	CcSEcCtD
Albendazole—Headache—Estradiol—osteoporosis	0.000321	0.00188	CcSEcCtD
Albendazole—TUBA1A—Cell Cycle, Mitotic—PSMA5—osteoporosis	0.000319	0.00198	CbGpPWpGaD
Albendazole—TUBA1A—Cell Cycle, Mitotic—PSMA2—osteoporosis	0.000319	0.00198	CbGpPWpGaD
Albendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—OXCT1—osteoporosis	0.000315	0.00195	CbGpPWpGaD
Albendazole—TUBB4B—Metabolism of proteins—TUBA1B—osteoporosis	0.000311	0.00193	CbGpPWpGaD
Albendazole—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.00031	0.00193	CbGpPWpGaD
Albendazole—CYP1A1—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.000306	0.0019	CbGpPWpGaD
Albendazole—CYP1A2—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.000305	0.0019	CbGpPWpGaD
Albendazole—Nausea—Estradiol—osteoporosis	0.000304	0.00178	CcSEcCtD
Albendazole—CYP1A1—Arachidonic acid metabolism—GPX1—osteoporosis	0.000292	0.00181	CbGpPWpGaD
Albendazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.000291	0.0018	CbGpPWpGaD
Albendazole—ABCB1—HIF-1-alpha transcription factor network—ENO1—osteoporosis	0.000287	0.00178	CbGpPWpGaD
Albendazole—CYP3A4—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.000287	0.00178	CbGpPWpGaD
Albendazole—TUBA1A—Cell Cycle—PSMA2—osteoporosis	0.000285	0.00177	CbGpPWpGaD
Albendazole—TUBA1A—Cell Cycle—PSMA5—osteoporosis	0.000285	0.00177	CbGpPWpGaD
Albendazole—TUBB4B—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000279	0.00173	CbGpPWpGaD
Albendazole—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—osteoporosis	0.000274	0.0017	CbGpPWpGaD
Albendazole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	0.000272	0.00169	CbGpPWpGaD
Albendazole—CYP1A1—Aryl Hydrocarbon Receptor—ESR1—osteoporosis	0.000256	0.00159	CbGpPWpGaD
Albendazole—CYP1A1—Biological oxidations—CYP27A1—osteoporosis	0.000254	0.00158	CbGpPWpGaD
Albendazole—CYP1A1—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000252	0.00156	CbGpPWpGaD
Albendazole—CYP1A1—Metapathway biotransformation—CYP27A1—osteoporosis	0.000251	0.00156	CbGpPWpGaD
Albendazole—TUBB4B—Metabolism of proteins—RPL24—osteoporosis	0.000249	0.00155	CbGpPWpGaD
Albendazole—CYP1A2—Tryptophan metabolism—CYP19A1—osteoporosis	0.000245	0.00152	CbGpPWpGaD
Albendazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.000236	0.00146	CbGpPWpGaD
Albendazole—TUBB4B—Metabolism of proteins—TLN1—osteoporosis	0.000219	0.00136	CbGpPWpGaD
Albendazole—TUBA1A—Metabolism of proteins—ACE—osteoporosis	0.000217	0.00135	CbGpPWpGaD
Albendazole—TUBB4B—Metabolism of proteins—REN—osteoporosis	0.00021	0.00131	CbGpPWpGaD
Albendazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	0.00021	0.00131	CbGpPWpGaD
Albendazole—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.000198	0.00123	CbGpPWpGaD
Albendazole—CYP1A2—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.000195	0.00121	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle, Mitotic—PSMA2—osteoporosis	0.000193	0.0012	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle, Mitotic—PSMA5—osteoporosis	0.000193	0.0012	CbGpPWpGaD
Albendazole—CYP3A4—Tryptophan metabolism—CYP19A1—osteoporosis	0.000189	0.00117	CbGpPWpGaD
Albendazole—CYP1A1—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.000186	0.00116	CbGpPWpGaD
Albendazole—CYP1A2—Arachidonic acid metabolism—GPX1—osteoporosis	0.000186	0.00116	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle—PSMA2—osteoporosis	0.000172	0.00107	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle—PSMA5—osteoporosis	0.000172	0.00107	CbGpPWpGaD
Albendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—osteoporosis	0.000171	0.00106	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.00017	0.00106	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—osteoporosis	0.000163	0.00101	CbGpPWpGaD
Albendazole—CYP1A2—Biological oxidations—CYP27A1—osteoporosis	0.000162	0.00101	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.000161	0.001	CbGpPWpGaD
Albendazole—ABCB1—HIF-1-alpha transcription factor network—LEP—osteoporosis	0.000161	0.000997	CbGpPWpGaD
Albendazole—CYP1A2—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.00016	0.000996	CbGpPWpGaD
Albendazole—CYP1A2—Metapathway biotransformation—CYP27A1—osteoporosis	0.00016	0.000993	CbGpPWpGaD
Albendazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.000153	0.000948	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—RAP1A—osteoporosis	0.000152	0.000943	CbGpPWpGaD
Albendazole—CYP1A1—Phase 1 - Functionalization of compounds—POMC—osteoporosis	0.000151	0.000939	CbGpPWpGaD
Albendazole—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.000151	0.000935	CbGpPWpGaD
Albendazole—TUBA1A—Metabolism of proteins—LEP—osteoporosis	0.000135	0.000838	CbGpPWpGaD
Albendazole—CYP1A1—Biological oxidations—CYP19A1—osteoporosis	0.000134	0.00083	CbGpPWpGaD
Albendazole—CYP1A1—Aryl Hydrocarbon Receptor—MYC—osteoporosis	0.000133	0.000828	CbGpPWpGaD
Albendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—osteoporosis	0.000133	0.000826	CbGpPWpGaD
Albendazole—CYP1A1—Metapathway biotransformation—CYP19A1—osteoporosis	0.000132	0.000818	CbGpPWpGaD
Albendazole—TUBB4B—Metabolism of proteins—ACE—osteoporosis	0.000131	0.000815	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	0.000125	0.000778	CbGpPWpGaD
Albendazole—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	0.000125	0.000777	CbGpPWpGaD
Albendazole—CYP1A1—Aryl Hydrocarbon Receptor—TNF—osteoporosis	0.000124	0.000771	CbGpPWpGaD
Albendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—osteoporosis	0.000124	0.000771	CbGpPWpGaD
Albendazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000124	0.000768	CbGpPWpGaD
Albendazole—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	0.000123	0.000766	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	0.000122	0.000759	CbGpPWpGaD
Albendazole—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.000119	0.000738	CbGpPWpGaD
Albendazole—TUBA1A—Metabolism of proteins—POMC—osteoporosis	0.000116	0.00072	CbGpPWpGaD
Albendazole—TUBA1A—Metabolism of proteins—IGF1—osteoporosis	0.000112	0.000693	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—osteoporosis	0.000109	0.000678	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.000108	0.000673	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	0.000108	0.000671	CbGpPWpGaD
Albendazole—TUBB4B—Transmembrane transport of small molecules—ADCY5—osteoporosis	0.000105	0.00065	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.000103	0.000638	CbGpPWpGaD
Albendazole—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—osteoporosis	0.000101	0.000629	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	9.77e-05	0.000606	CbGpPWpGaD
Albendazole—CYP1A2—Phase 1 - Functionalization of compounds—POMC—osteoporosis	9.64e-05	0.000598	CbGpPWpGaD
Albendazole—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	9.18e-05	0.00057	CbGpPWpGaD
Albendazole—TUBA1A—Cell Cycle, Mitotic—MYC—osteoporosis	8.99e-05	0.000558	CbGpPWpGaD
Albendazole—ABCB1—Allograft Rejection—IL1B—osteoporosis	8.87e-05	0.000551	CbGpPWpGaD
Albendazole—CYP1A2—Biological oxidations—CYP19A1—osteoporosis	8.52e-05	0.000529	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor—MYC—osteoporosis	8.5e-05	0.000528	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—ANXA2—osteoporosis	8.49e-05	0.000527	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—osteoporosis	8.48e-05	0.000526	CbGpPWpGaD
Albendazole—CYP1A2—Metapathway biotransformation—CYP19A1—osteoporosis	8.4e-05	0.000522	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	8.3e-05	0.000516	CbGpPWpGaD
Albendazole—TUBB4B—Metabolism of proteins—LEP—osteoporosis	8.15e-05	0.000506	CbGpPWpGaD
Albendazole—TUBA1A—Cell Cycle—MYC—osteoporosis	8.04e-05	0.000499	CbGpPWpGaD
Albendazole—CYP1A1—Biological oxidations—POMC—osteoporosis	8.03e-05	0.000499	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	7.99e-05	0.000496	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—osteoporosis	7.92e-05	0.000492	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor—TNF—osteoporosis	7.92e-05	0.000492	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	7.79e-05	0.000484	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—FDPS—osteoporosis	7.57e-05	0.00047	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PKM—osteoporosis	7.57e-05	0.00047	CbGpPWpGaD
Albendazole—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	7.44e-05	0.000462	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—GPD2—osteoporosis	7.18e-05	0.000446	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PGLS—osteoporosis	7.18e-05	0.000446	CbGpPWpGaD
Albendazole—TUBB4B—Metabolism of proteins—POMC—osteoporosis	7e-05	0.000435	CbGpPWpGaD
Albendazole—ABCB1—Allograft Rejection—TGFB1—osteoporosis	6.89e-05	0.000428	CbGpPWpGaD
Albendazole—TUBB4B—Metabolism of proteins—IGF1—osteoporosis	6.74e-05	0.000418	CbGpPWpGaD
Albendazole—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	6.57e-05	0.000408	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PNP—osteoporosis	6.57e-05	0.000408	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—ATIC—osteoporosis	6.57e-05	0.000408	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	6.55e-05	0.000407	CbGpPWpGaD
Albendazole—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	6.48e-05	0.000403	CbGpPWpGaD
Albendazole—ABCB1—Allograft Rejection—TNF—osteoporosis	6.44e-05	0.0004	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	6.23e-05	0.000387	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—FDPS—osteoporosis	6.05e-05	0.000376	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PKM—osteoporosis	6.05e-05	0.000376	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—GPD2—osteoporosis	5.73e-05	0.000356	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PGLS—osteoporosis	5.73e-05	0.000356	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	5.67e-05	0.000352	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—OXCT1—osteoporosis	5.58e-05	0.000347	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—CA2—osteoporosis	5.58e-05	0.000347	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—MGLL—osteoporosis	5.44e-05	0.000338	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle, Mitotic—MYC—osteoporosis	5.43e-05	0.000337	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	5.29e-05	0.000329	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PNP—osteoporosis	5.24e-05	0.000326	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—ATIC—osteoporosis	5.24e-05	0.000326	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	5.13e-05	0.000319	CbGpPWpGaD
Albendazole—CYP1A2—Biological oxidations—POMC—osteoporosis	5.12e-05	0.000318	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle—MYC—osteoporosis	4.86e-05	0.000302	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PKM—osteoporosis	4.83e-05	0.0003	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—FDPS—osteoporosis	4.83e-05	0.0003	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—IDH2—osteoporosis	4.63e-05	0.000287	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—GPD2—osteoporosis	4.58e-05	0.000284	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PGLS—osteoporosis	4.58e-05	0.000284	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CA2—osteoporosis	4.46e-05	0.000277	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—OXCT1—osteoporosis	4.46e-05	0.000277	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—CYP27A1—osteoporosis	4.35e-05	0.00027	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—MGLL—osteoporosis	4.35e-05	0.00027	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—ACP5—osteoporosis	4.23e-05	0.000263	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ATIC—osteoporosis	4.19e-05	0.00026	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PNP—osteoporosis	4.19e-05	0.00026	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	4.18e-05	0.000259	CbGpPWpGaD
Albendazole—CYP3A4—Biological oxidations—POMC—osteoporosis	3.95e-05	0.000245	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—TPI1—osteoporosis	3.93e-05	0.000244	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—FDPS—osteoporosis	3.73e-05	0.000231	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PKM—osteoporosis	3.73e-05	0.000231	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—P4HB—osteoporosis	3.7e-05	0.00023	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—IDH2—osteoporosis	3.69e-05	0.000229	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—GAPDH—osteoporosis	3.63e-05	0.000225	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—OXCT1—osteoporosis	3.56e-05	0.000221	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CA2—osteoporosis	3.56e-05	0.000221	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—RAP1A—osteoporosis	3.54e-05	0.00022	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GPD2—osteoporosis	3.53e-05	0.000219	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PGLS—osteoporosis	3.53e-05	0.000219	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CYP27A1—osteoporosis	3.47e-05	0.000216	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—MGLL—osteoporosis	3.47e-05	0.000215	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	3.41e-05	0.000212	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	3.4e-05	0.000211	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—ACP5—osteoporosis	3.38e-05	0.00021	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	3.27e-05	0.000203	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PNP—osteoporosis	3.23e-05	0.000201	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ATIC—osteoporosis	3.23e-05	0.000201	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	3.18e-05	0.000198	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	3.18e-05	0.000197	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—TPI1—osteoporosis	3.14e-05	0.000195	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	3.08e-05	0.000191	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—P4HB—osteoporosis	2.95e-05	0.000183	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—IDH2—osteoporosis	2.95e-05	0.000183	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—GAPDH—osteoporosis	2.9e-05	0.00018	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—ENO1—osteoporosis	2.86e-05	0.000177	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—RAP1A—osteoporosis	2.82e-05	0.000175	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PSMA5—osteoporosis	2.82e-05	0.000175	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PSMA2—osteoporosis	2.82e-05	0.000175	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CYP27A1—osteoporosis	2.77e-05	0.000172	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CA2—osteoporosis	2.75e-05	0.000171	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—OXCT1—osteoporosis	2.75e-05	0.000171	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ACP5—osteoporosis	2.7e-05	0.000168	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—MGLL—osteoporosis	2.68e-05	0.000166	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.66e-05	0.000165	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—TPI1—osteoporosis	2.51e-05	0.000156	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—P4HB—osteoporosis	2.36e-05	0.000146	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—GAPDH—osteoporosis	2.31e-05	0.000144	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—CYP19A1—osteoporosis	2.28e-05	0.000142	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—ENO1—osteoporosis	2.28e-05	0.000142	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—IDH2—osteoporosis	2.28e-05	0.000141	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—RAP1A—osteoporosis	2.25e-05	0.00014	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PSMA2—osteoporosis	2.25e-05	0.00014	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PSMA5—osteoporosis	2.25e-05	0.00014	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CYP27A1—osteoporosis	2.14e-05	0.000133	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ACP5—osteoporosis	2.08e-05	0.000129	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.97e-05	0.000122	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—TPI1—osteoporosis	1.94e-05	0.00012	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—ADCY5—osteoporosis	1.87e-05	0.000116	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—GPX1—osteoporosis	1.86e-05	0.000116	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CYP19A1—osteoporosis	1.82e-05	0.000113	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ENO1—osteoporosis	1.82e-05	0.000113	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—P4HB—osteoporosis	1.82e-05	0.000113	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PSMA2—osteoporosis	1.8e-05	0.000111	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PSMA5—osteoporosis	1.8e-05	0.000111	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GAPDH—osteoporosis	1.79e-05	0.000111	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—RAP1A—osteoporosis	1.74e-05	0.000108	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—MTHFR—osteoporosis	1.72e-05	0.000107	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—ADCY5—osteoporosis	1.49e-05	9.26e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—GPX1—osteoporosis	1.49e-05	9.23e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CYP19A1—osteoporosis	1.46e-05	9.05e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ENO1—osteoporosis	1.41e-05	8.73e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PSMA5—osteoporosis	1.39e-05	8.6e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PSMA2—osteoporosis	1.39e-05	8.6e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—POMC—osteoporosis	1.37e-05	8.53e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—MTHFR—osteoporosis	1.37e-05	8.51e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ADCY5—osteoporosis	1.19e-05	7.39e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—GPX1—osteoporosis	1.19e-05	7.37e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CYP19A1—osteoporosis	1.12e-05	6.98e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—POMC—osteoporosis	1.1e-05	6.81e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—MTHFR—osteoporosis	1.09e-05	6.8e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ADCY5—osteoporosis	9.19e-06	5.7e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GPX1—osteoporosis	9.15e-06	5.68e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—POMC—osteoporosis	8.76e-06	5.44e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—MTHFR—osteoporosis	8.45e-06	5.25e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—POMC—osteoporosis	6.76e-06	4.2e-05	CbGpPWpGaD
